» Authors » Nicoletta Zoppi

Nicoletta Zoppi

Explore the profile of Nicoletta Zoppi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 837
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chiarelli N, Cinquina V, Zoppi N, Bertini V, Maddaluno M, De Leonibus C, et al.
Biomedicines . 2025 Jan; 12(12. PMID: 39767655
: Dominant mutations in are known to cause vascular Ehlers-Danlos syndrome (vEDS) by impairing extracellular matrix (ECM) homeostasis. This disruption leads to the fragility of soft connective tissues and a...
2.
Ritelli M, Chiarelli N, Cinquina V, Bertini V, Piantoni S, Caproli A, et al.
Am J Med Genet A . 2024 Sep; 197(1):e63857. PMID: 39225014
Diagnosing hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD), common overlapping multisystemic conditions featuring symptomatic joint hypermobility, is challenging due to lack of established causes and diagnostic tools. Currently,...
3.
Chiarelli N, Cinquina V, Martini P, Bertini V, Zoppi N, Venturini M, et al.
Biochim Biophys Acta Mol Basis Dis . 2023 Oct; 1870(1):166915. PMID: 37827202
Vascular Ehlers-Danlos syndrome (vEDS) is a severe connective tissue disorder caused by dominant mutations in the COL3A1 gene encoding type III collagen (COLLIII). COLLIII is primarily found in blood vessels...
4.
Fortugno P, Monetta R, Cinquina V, Rigon C, Boaretto F, De Luca C, et al.
Eur J Hum Genet . 2023 Jan; 31(5):596-601. PMID: 36599937
Pathogenic variants in TGFBR1 are a common cause of Loeys-Dietz syndrome (LDS) characterized by life-threatening aortic and arterial disease. Generally, these are missense changes in highly conserved amino acids in...
5.
Ritelli M, Chiarelli N, Cinquina V, Zoppi N, Bertini V, Venturini M, et al.
Cells . 2022 Dec; 11(24). PMID: 36552803
Hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD) are clinically overlapping connective tissue disorders of unknown etiology and without any validated diagnostic biomarker and specific therapies. Herein, we in-depth...
6.
Chiarelli N, Zoppi N, Venturini M, Capitanio D, Gelfi C, Ritelli M, et al.
Cells . 2021 Nov; 10(11). PMID: 34831458
Hypermobile Ehlers-Danlos syndrome (hEDS) is the most frequent type of EDS and is characterized by generalized joint hypermobility and musculoskeletal manifestations which are associated with chronic pain, and mild skin...
7.
Chiarelli N, Zoppi N, Ritelli M, Venturini M, Capitanio D, Gelfi C, et al.
Biochim Biophys Acta Mol Basis Dis . 2020 Dec; 1867(4):166051. PMID: 33383104
Hypermobile Ehlers-Danlos syndrome (hEDS), mainly characterized by generalized joint hypermobility and its complications, minor skin changes, and apparently segregating with an autosomal dominant pattern, is still without a known molecular...
8.
Micale L, Morlino S, Biagini T, Carbone A, Fusco C, Ritelli M, et al.
Biochim Biophys Acta Mol Basis Dis . 2020 Feb; 1866(6):165742. PMID: 32105826
Transforming growth factor beta-activated kinase 1 (TAK1) is a highly conserved kinase protein encoded by MAP3K7, and activated by multiple extracellular stimuli, growth factors and cytokines. Heterozygous variants in MAP3K7...
9.
Morlino S, Micale L, Ritelli M, Rohrbach M, Zoppi N, Vandersteen A, et al.
Clin Genet . 2019 Dec; 97(3):396-406. PMID: 31794058
The 2017 classification of Ehlers-Danlos syndromes (EDS) identifies three types associated with causative variants in COL1A1/COL1A2 and distinct from osteogenesis imperfecta (OI). Previously, patients have been described with variable features...
10.
Li J, Ritelli M, Ma C, Rao G, Habib T, Corvilain E, et al.
Sci Immunol . 2019 Dec; 4(41). PMID: 31784499
Genetic etiologies of chronic mucocutaneous candidiasis (CMC) disrupt human IL-17A/F-dependent immunity at mucosal surfaces, whereas those of connective tissue disorders (CTDs) often impair the TGF-β-dependent homeostasis of connective tissues. The...